104292-65-1

Basic information

• Product Name: benzyl 3,4-anhydro-β-L-ribopyranoside
• Synonyms: benzyl 3,4-anhydro-β-L-ribopyranoside
• CAS NO: 104292-65-1
• Molecular Weight: 222.241
• Mol File: 104292-65-1.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: benzyl 3,4-anhydro-β-L-ribopyranoside(CAS DataBase Reference)
• NIST Chemistry Reference: benzyl 3,4-anhydro-β-L-ribopyranoside(104292-65-1)
• EPA Substance Registry System: benzyl 3,4-anhydro-β-L-ribopyranoside(104292-65-1)

Safety Data

• Hazardous Substances Data: 104292-65-1(Hazardous Substances Data)

Upstream product

• 104292-63-9 benzyl 4-bromo-4-deoxy-α-D-lyxopyranoside 
• 26685-74-5 1-O-benzyl-3,4-O-isopropylidene-β-L-ribopyranose 
• 209787-64-4 benzyl 2,3-O-isopropylidene-α-D-lyxopyranoside 
• 100-51-6 benzyl alcohol 
• 103773-81-5 1-O-benzyl-2,3-isopropylidene-L-lyxopyranose 
• 136845-03-9 Methanesulfonic acid (3aR,7S,7aS)-4-benzyloxy-2,2-dimethyl-tetrahydro-[1,3]dioxolo[4,5-c]pyran-7-yl ester 
• 18403-17-3 Methanesulfonic acid (3S,4S,5R)-6-benzyloxy-4,5-dihydroxy-tetrahydro-pyran-3-yl ester 

Downstream Products

• 104292-69-5 benzyl 3,4-anhydro-β-L-erythropentopyranosid-2-ulose 
• 275363-98-9 4-epi-isofagomine 
• 104322-43-2 benzyl 3,4-anhydro-2-deuterio-β-L-ribopyranoside 
• 104292-76-4 2(S)-(benzyloxy)-3-deuterio-2,5-dihydrofuran-4-carboxaldehyde 
• 498-60-2 furan-3-carboxaldehyde 
• 123836-20-4 [(E)-(1S,2R)-5-((3aR,7S,7aR)-4-Benzyloxy-2,2-dimethyl-tetrahydro-[1,3]dioxolo[4,5-c]pyran-7-yl)-1,2-dimethyl-pent-3-enyloxy]-tert-butyl-dimethyl-silane 
• 123836-17-9 (3aR,7S,7aS)-4-Benzyloxy-7-iodo-2,2-dimethyl-tetrahydro-[1,3]dioxolo[4,5-c]pyran 

Relevant articles and documents

Iminosugar-based galactoside mimics as inhibitors of galactocerebrosidase: SAR studies and comparison with other lysosomal galactosidases

Several families of iminosugar-based galactoside mimics were designed, synthesized, and evaluated as galactocerebrosidase (GALC) inhibitors. They were also tested as inhibitors of lysosomal β- and α-galactosidases in order to find new potent and selective pharmacological chaperones for treatment of the lysosomal storage disorder, Krabbe disease. Whereas 1-C-alkyl imino-l-arabinitols are totally inactive toward the three enzymes, 1-C-alkyl imino-L-galactitols were found to be active only toward α-galactosidase A. Finally, 1-N-iminosugars provided the best results, as 4-epi-isofagomine was found to be a good inhibitor of both lysosomal β-galactosidase and GALC. Further elaboration of this structure is required to achieve selectivity between these two galactosidases.

Free-radical addition-fragmentation reactions in synthesis: A 'second generation' synthesis of (+)- pseudomonic acid C

-